Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05833555 · ClinicalTrials.gov registry record · NA

Harlem Strong Mental Health Coalition

A NA study of Depression, Anxiety and Mental Health Wellness, sponsored by City University of New York, School of Public Health.

Recruiting
Registry status
NA
Development phase
700
Enrollment target
2
Study locations

NCT05833555: Recruiting NA study of Depression, Anxiety and Mental Health Wellness, sponsored by City University of New York, School of Public Health.

NCT05833555 is a NA study of Depression, Anxiety and Mental Health Wellness that is actively recruiting participants, run by City University of New York, School of Public Health. The registered enrollment target is 700 participants, above the 407-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (72% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05833555, a NA study of Depression, Anxiety and Mental Health Wellness, is actively recruiting participants, sponsored by City University of New York, School of Public Health.

RECRUITING
Registry status
NA
Development phase
700 participants
Enrollment target
2
Study locations

Study Summary

Addressing health disparities, especially in the face of coronavirus pandemic, requires an integrated multi-sector equity-focused, community-based approach. This study will examine the impact of Harlem Strong Community Mental Health Collaborative, a community-wide multi-sectoral coalition in which a health insurer works with a network of community-based organizations, medical providers, and behavioral health providers to engage in a network-wide implementation planning process to: (1) problem-solve financing, access, and quality of care barriers, (2) support capacity building for mental health (MH) task-sharing for community health workers, (3) facilitate coordination and collaboration across MH/behavioral health, primary care, and a range of social services, including case management, housing supports, financial education, employment support, and other community resources to improve linkages to services, and (4) identify a set of common MH, social risk, and health metrics and strategies to integrate these metrics into data systems across the network for continuous quality improvement of the system. The long-term goal of our study is to develop sustainable model for task-sharing MH care that will be embedded in a coordinated comprehensive network of services, including primary care, behavioral/MH, social services, and other community resources.

Primary Outcome

Depression symptom severity is assessed using the Patient Health Questionnaire (PHQ-9), which includes nine items on a scale ranging from "0" (Not at all) to "3" (Nearly every day). PHQ-9 scores range from 0 to 27, with higher scores indicating greater severity of depression. The scores are categorized into five levels: minimal (0-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20-27).

Interventions

  • BEHAVIORAL Learning Collaborative
  • BEHAVIORAL MH task-sharing training
  • BEHAVIORAL Supervision
  • OTHER Technology Intervention

Study Locations (2)

New York

  • CUNY Graduate School of Public Health and Health Policy - New York
  • Harlem Congregation for Community Improvement - New York

Trial Details

FieldValue
Enrollment Target 700 participants
Start Date 2023-04-05
Est. Completion 2026-08-31
Phase NA

What NCT05833555 shows while recruiting

NCT05833555 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, above the 407-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (72% higher).

The record links to 3 conditions, with Depression, Anxiety appearing as the primary indexed condition, and to 4 interventions - of which Learning Collaborative is the first listed.

NCT05833555 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05833555 about?

NCT05833555 is a clinical study titled "Harlem Strong Mental Health Coalition". Addressing health disparities, especially in the face of coronavirus pandemic, requires an integrated multi-sector equity-focused, community-based approach. This study will examine the impact of Harlem Strong Community Mental Health Collaborative, a community-wide multi-sectoral coalition in which a...

What is the current status of trial NCT05833555?

This trial is currently recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2023-04-05. Estimated completion is 2026-08-31.

What conditions does trial NCT05833555 study?

This clinical trial studies the following conditions: Depression, Anxiety, Mental Health Wellness, Stress-related Problem.

What interventions are being tested in trial NCT05833555?

The interventions under investigation include: Learning Collaborative (BEHAVIORAL), MH task-sharing training (BEHAVIORAL), Supervision (BEHAVIORAL), Technology Intervention (OTHER).

Who is sponsoring clinical trial NCT05833555?

This trial is sponsored by City University of New York, School of Public Health, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05833555 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression, Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05833555's enrollment target sits among peer trials

700 4th of 40 higher than 37 of 40 other Depression, Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression, Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900419 · 700 participants

    Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

  • NCT01804686 · 700 participants · Phase 3

    A Long-term Extension Study of PCI-32765 (Ibrutinib)

  • NCT02107989 · 700 participants

    Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

  • NCT02129543 · 700 participants

    Immune Reconstitution in Stem Cell Transplant Recipients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05833555, the US trial registry maintained by the National Library of Medicine. NCT05833555 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.